Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures
Athe M.N. Tsibris, Zixin Hu, Roger Paredes, Kay E. Leopold, Opass Putcharoen, Allison L. Schure, Natalie Mazur, Eoin Coakley, Zhaohui Su, Roy M. Gulick, Daniel R. Kuritzkes
Profundice en los temas de investigación de 'Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures'. En conjunto forman una huella única.